CHEMOSAT® hepatic delivery system offers isolated whole organ liver direct therapy for the treatment of ocular melanoma liver metastases and other cancers of the liver.

Indications for use

The CHEMOSAT® hepatic delivery system is used for percutaneous intra-arterial administration of a chemotherapeutic agent (melphalan hydrochloride) to the liver with subsequent extracorporeal filtration of the regional (hepatic) venous blood, lowering the concentration of a chemotherapeutic agent in the blood before returning it to the systemic venous circulation.